Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 40: 454-458, 1994;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Rorke, A.
Right arrow Articles by Fottrell, P. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Rorke, A.
Right arrow Articles by Fottrell, P. F.

Clinical Chemistry, Vol 40, 454-458, Copyright © 1994 by American Association for Clinical Chemistry

Development and validation of a monoclonal antibody enzyme immunoassay for measuring progesterone in saliva

A O'Rorke, MM Kane, JP Gosling, DF Tallon and PF Fottrell
Department of Biochemistry, Bioresearch Ireland, University College, Galway.

A nonextraction, competitive, solid-phase enzyme immunoassay with a monoclonal antibody was developed and validated for measuring progesterone in saliva. The antibody was raised against 11 alpha- hydroxyprogesterone hemisuccinate-bovine serum albumin conjugate and was indirectly immobilized to the walls of microtiter wells. The labeled analyte (progesterone-horseradish peroxidase conjugate) was homologous with the immunogen. The lower detection limit (concentration equivalent to B0-3 SD) was 38 pmol/L of saliva sample. We validated the assay with studies to establish the independence of the concentration determined from the volume of saliva assayed, quantitative recovery of progesterone added to saliva, interference from possible cross- reactants, and agreement with a similar assay that incorporated an extraction step. In addition, we determined luteal-phase concentrations of salivary progesterone in normal women and compared the results with those of an older assay involving a polyclonal antibody.


The following articles in journals at HighWire Press have cited this article:


Home page
J. Exp. Biol.Home page
T. D. Brutsaert, H. Spielvogel, E. Caceres, M. Araoz, R. T. Chatterton, and V. J. Vitzthum
Effect of menstrual cycle phase on exercise performance of high-altitude native women at 3600 m
J. Exp. Biol., January 15, 2002; 205(2): 233 - 239.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Tamate, M. Charleton, J. P. Gosling, D. Egan, M. Ishikawa, P. F. Fottrell, and M. M. Kane
Direct colorimetric monoclonal antibody enzyme immunoassay for estradiol-17{beta} in saliva
Clin. Chem., July 1, 1997; 43(7): 1159 - 1164.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Association for Clinical Chemistry.